相关实验视频

Updated: Jun 14, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

移植后并发症:分子机制和治疗干预措施

Xiaoyou Liu¹, Junyi Shen², Hongyan Yan¹

¹Department of Organ transplantation The First Affiliated Hospital, Guangzhou Medical University Guangzhou China.

|September 3, 2024

概括

移植后的并发症显著影响器官移植的生存率. 了解它们的分子机制是开发精准医学策略以获得更好的患者结果的关键.

科学领域:

移植免疫学移植免疫学
分子医学是分子医学.
在瘤学瘤学.

背景情况:

移植后的并发症是长期器官移植生存和接受者的生活质量的主要障碍.
这些并发症包括免疫媒介问题,感染,代谢问题和恶性瘤,每个都有不同的风险因素和机制.

研究的目的:

提供对主要移植后并发症的临床特征,风险因素和分子机制的全面概述.
总结当前关于全移植排斥,移植与宿主疾病,免疫抑制剂的代谢失调以及与病毒相关的恶性瘤的知识.
讨论预防和干预策略,并强调在并发症管理中需要精准医学.

主要方法:

对移植后并发症的现有文献进行系统审查和总结.
对涉及免疫学,代谢和瘤过程的分子机制的分析.
讨论临床特征,风险因素和治疗方法.

主要成果:

移植后并发症是由于复杂的相互作用引起的,包括免疫激活,免疫抑制剂副作用和病毒再激活.
关键的关注领域包括全移植排斥,移植对宿主疾病,代谢综合征和移植后淋巴增殖性疾病.
目前的战略重点是优化免疫抑制,感染预防和向治疗.

结论:

对分子机制的彻底理解对于管理移植后并发症至关重要.
优化免疫抑制疗法和感染控制对于改善患者的治疗结果至关重要.
未来的研究应该集中在精准医学上,以开发个性化的并发症管理策略,并提高移植受体的预后.

关键词:

一个T细胞细胞.感染感染的感染.恶性瘤是一种恶性瘤.器官移植器官移植器官移植器官移植移植后并发症移植后并发症拒绝拒绝拒绝拒绝

更多相关视频

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Murine Full-thickness Skin Transplantation

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

相关概念视频

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...